Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Trillions.
The item "Begin-Period-Cashflow" stands at 1.07 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 06/30/2021.
Kyowa Kirin Co Ltd's second quarter result of 0.2144 Trillion JPY for the item "Begin Period Cashflow" represents a decrease of -12.39 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 0.2144 Trillion JPY for the item "Begin Period Cashflow" represents a decrease of -35.65 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 1.07 Trillion JPY for the item "Begin Period Cashflow" represents a decrease of -10.02 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -28.45 percent compared to the value the year prior.
The 1 year change in percent is -28.45.
The 3 year change in percent is -16.99.
The 5 year change in percent is 603.04.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Begin Period Cashflow | 905,699,262,464.00 |
![]() | Johnson & Johnson - Begin Period Cashflow | 486,508,953,600.00 |
![]() | AbbVie Inc - Begin Period Cashflow | 399,570,305,024.00 |
![]() | Roche Holding AG - Begin Period Cashflow | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Begin Period Cashflow | 280,205,508,085.11 |